Results 201 to 210 of about 514,225 (378)

Photodynamic Treatment of 206 Thin (≤ 1 mm) Basal Cell Carcinomas Using a Biphasic Activation Protocol: The Outcomes Over a 7‐Year Period and the Rationale Behind the Treatment

JEADV Clinical Practice, EarlyView.
Photodynamic treatment using a 2‐phased activation protocol consisting of red light followed immediately by IPL delivered with mechanical pressure to squeeze out blood was highly successful in a group of 206 thin BCCs ( ≤ 1 mm maximum thickness). Optical coherence tomography (OCT) was used for triage and to monitor outcomes.
Robert Stephens, Chris D. Anderson, Rolf B. Saager, Antony Johnston, Dariush Adybeik   +4 more
wiley   +1 more source

Transportation barriers, emergency department use, and mortality risk among us adults: a national health interview survey analysis. [PDF]

BMC Public Health
Chen F, Nipp RD, Han X, Zheng Z, Yabroff KR, Wang T, Jiang C.   +6 more
europepmc   +1 more source

Medicare Payment Policy and Recombinant Erythropoietin Prescribing for Dialysis Patients

, 1993
Neil R. Powe, Robert I. Griffiths, Gerard F. Anderson, Gregory de Lissovoy, Alan J. Watson, Joel Greer, Robert J. Herbert, Paul K. Whelton   +7 more
openalex   +1 more source

Inadequate Prescription-Drug Coverage for Medicare Enrollees — A Call to Action [PDF]

, 1999
Stephen B. Soumerai, Dennis Ross‐Degnan   +1 more
openalex   +1 more source

Characteristics of Adult Patients With Atopic Dermatitis Initiating Biologics and Janus Kinase Inhibitors in the CorEvitas Atopic Dermatitis Registry

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors.
Eric L. Simpson, Linda Stein Gold, Seemal R. Desai, Alexandra K. Golant, Douglas DiRuggiero, Christian Fenske, Yolanda Muñoz Maldonado, Alvin H. Li, Zach Dawson, Kaylee Ho, Kayla Callahan, Gaia Gallo, Jonathan I. Silverberg   +12 more
wiley   +1 more source

Decomposing Medicare total, Part D, and Part B drug payments among people with Alzheimer's disease and related diseases. [PDF]

Health Aff Sch
Chen J, Jang S.
europepmc   +1 more source

A description of the extreme aged population based on improved medicare enrollment data

, 1992
Bert Kestenbaum
openalex   +1 more source

The Silent Spread: A Systematic Review of Delayed Melanoma Diagnosis and Disease Progression During the COVID‐19 Pandemic

JEADV Clinical Practice, EarlyView.
ABSTRACT Background The COVID‐19 pandemic has significantly disrupted global healthcare systems. Melanoma, a highly aggressive skin cancer whose prognosis is closely tied to early detection, has been particularly impacted. Lockdowns, changes to healthcare resource reallocation and patient hesitancy in seeking care have all contributed to delays in ...
Akshay Soni, Elisha Purcell, Bryan Lim, Gianluca Marcaccini, Ishith Seth, Warren M. Rozen   +5 more
wiley   +1 more source

US cost–effectiveness analysis of apixaban compared with warfarin, dabigatran and rivaroxaban for nonvalvular atrial fibrillation, focusing on equal value of life years and health years in total

Journal of Comparative Effectiveness Research
Aim: Warfarin and direct-acting oral anticoagulants (DOACs) are widely prescribed to patients with nonvalvular atrial fibrillation (NVAF) to reduce risk of stroke and systemic embolism (SE). This study aimed to assess the cost–effectiveness of apixaban
Nipun Atreja, Kasper Johannesen, Rupesh Subash, Carina Bektur, Melissa Hagan, Dionne M Hines, Iulia Dunnett, Ewa Stawowczyk   +7 more
doaj   +1 more source

Trends in opioid prescribing by oncologists for Medicare beneficiaries from 2014 to 2022. [PDF]

J Manag Care Spec Pharm
Elshafie S, Villa Zapata L.
europepmc   +1 more source